In the March 27, 2013, Molecular Imaging posting, Kathy Fay Mahdoubi reported on  a study from the March issue of the Journal of Nuclear Medicine.  “Dominik Bettenworth, MD, from University of Münster’s Department of Medicine in Münster, Germany, and colleagues described how 18-F FDG PET/CT imaging provides a non-invasive means of evaluating patients with inflammatory bowel conditions by quantifying increased metabolic activity in diseased areas of the colon.”